E
BioAtla, Inc. BCAB
$0.356 -$0.0002-0.06% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -22.02% -3.02% -40.60% 49.76% 9.31%
Total Depreciation and Amortization -37.16% -19.74% 0.00% -0.44% -4.58%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 812.34% -120.91% -48.77% -12.10% 8.52%
Change in Net Operating Assets 410.64% 72.25% -207.22% 458.39% 91.65%
Cash from Operations 13.31% 2.95% -227.03% 73.26% 37.74%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -100.00% --
Repurchase of Common Stock 82.76% -- 100.00% 26.32% -46.15%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 78.69% -- -- -- --
Cash from Financing 90.89% -104.24% 66,621.43% -106.22% 1,830.77%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 15.15% -123.33% -45.16% 72.87% 38.50%